ZA200810859B - Process for the preparation of asenapine and intermediate products used in said process - Google Patents
Process for the preparation of asenapine and intermediate products used in said processInfo
- Publication number
- ZA200810859B ZA200810859B ZA200810859A ZA200810859A ZA200810859B ZA 200810859 B ZA200810859 B ZA 200810859B ZA 200810859 A ZA200810859 A ZA 200810859A ZA 200810859 A ZA200810859 A ZA 200810859A ZA 200810859 B ZA200810859 B ZA 200810859B
- Authority
- ZA
- South Africa
- Prior art keywords
- asenapine
- preparation
- intermediate products
- products used
- products
- Prior art date
Links
- VSWBSWWIRNCQIJ-GJZGRUSLSA-N (R,R)-asenapine Chemical compound O1C2=CC=CC=C2[C@@H]2CN(C)C[C@H]2C2=CC(Cl)=CC=C21 VSWBSWWIRNCQIJ-GJZGRUSLSA-N 0.000 title 1
- 229960005245 asenapine Drugs 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06116660 | 2006-07-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200810859B true ZA200810859B (en) | 2009-09-30 |
Family
ID=37685865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200810859A ZA200810859B (en) | 2006-07-05 | 2008-12-23 | Process for the preparation of asenapine and intermediate products used in said process |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2044076B1 (fr) |
JP (1) | JP2010503611A (fr) |
CN (1) | CN101484456B (fr) |
AR (1) | AR061811A1 (fr) |
AT (1) | ATE445620T1 (fr) |
CA (1) | CA2655670A1 (fr) |
CY (1) | CY1109707T1 (fr) |
DE (1) | DE602007002826D1 (fr) |
DK (1) | DK2044076T3 (fr) |
ES (1) | ES2333488T3 (fr) |
HK (1) | HK1127044A1 (fr) |
MX (1) | MX2008016490A (fr) |
PL (1) | PL2044076T3 (fr) |
PT (1) | PT2044076E (fr) |
SI (1) | SI2044076T1 (fr) |
TW (1) | TW200817414A (fr) |
WO (1) | WO2008003460A1 (fr) |
ZA (1) | ZA200810859B (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7875729B2 (en) * | 2007-01-05 | 2011-01-25 | Synthon Bv | Process for making asenapine |
JP2011508751A (ja) * | 2008-01-04 | 2011-03-17 | ナームローゼ・フエンノートチヤツプ・オルガノン | アセナピンの調製方法および前記方法において使用される中間生成物 |
KR101435296B1 (ko) | 2009-06-24 | 2014-08-27 | 머크 샤프 앤 도메 비.브이. | 아세나핀을 함유하는 주사가능한 제제 및 그를 사용한 치료 방법 |
WO2012123325A1 (fr) | 2011-03-11 | 2012-09-20 | Medichem S.A. | Nouvelles formes cristallines du sel de trans-5-chloro-2-méthyl-2,3,3a,12b-tétrahydro-1h-dibenzo[2,3:6,7] oxépino[4,5-c]pyrrole avec l'acide maléique |
CN102229613B (zh) * | 2011-04-27 | 2013-08-07 | 上海华升生物科技有限公司 | 阿森纳平的合成工艺 |
ITMI20110734A1 (it) * | 2011-05-02 | 2012-11-03 | Olon Spa | Sali cristallini di asenapina |
EP2524921A1 (fr) * | 2011-05-17 | 2012-11-21 | Sandoz AG | Nouveaux sels cristallins d'asénapine |
EP2524919A1 (fr) * | 2011-05-17 | 2012-11-21 | Sandoz AG | Nouveaux sels cristallins d'asénapine avec des di-acides et des tri-acides cristallins |
CN102952144A (zh) * | 2011-08-29 | 2013-03-06 | 上海华拓医药科技发展股份有限公司 | 阿森纳平马来酸盐的晶型、制备方法及其药物组合物 |
EP2572703A1 (fr) | 2011-09-21 | 2013-03-27 | Hexal AG | Forme pharmaceutique orale compressée pour maléate d'asénapine |
WO2013041604A1 (fr) | 2011-09-21 | 2013-03-28 | Sandoz Ag | Forme cristalline de maléate d'asénapine |
GB201121124D0 (en) * | 2011-12-08 | 2012-01-18 | Dow Corning | Hydrolysable silanes |
GB201121128D0 (en) * | 2011-12-08 | 2012-01-18 | Dow Corning | Treatment of filler with silane |
CN103183680A (zh) * | 2011-12-27 | 2013-07-03 | 上海华拓医药科技发展股份有限公司 | 阿森那平的制备方法 |
WO2013190481A1 (fr) * | 2012-06-21 | 2013-12-27 | Alembic Pharmaceuticals Limited | Procédé pour la préparation d'asénapine et sels d'intermédiaires de celle-ci |
CN103772402A (zh) * | 2014-01-07 | 2014-05-07 | 万特制药(海南)有限公司 | 一种新的阿塞那平马来酸盐粗品精制方法 |
CN104974167B (zh) * | 2014-04-02 | 2019-01-04 | 洋浦慧谷医药有限公司 | 阿塞那平的制备方法以及用于制备阿塞那平的中间体 |
US10056563B2 (en) | 2016-04-08 | 2018-08-21 | Samsung Electronics Co., Ltd. | Synthetic method of fused heteroaromatic compound and fused heteroaromatic compound, and intermediate thereof |
KR102677490B1 (ko) | 2016-11-08 | 2024-06-20 | 삼성전자주식회사 | 축합 헤테로방향족 화합물의 합성 방법, 축합 헤테로방향족 화합물 및 그 중간체 및 합성 방법 |
RU2764443C2 (ru) | 2016-12-20 | 2022-01-17 | Лтс Ломанн Терапи-Систем Аг | Трансдермальная терапевтическая система, содержащая азенапин и полисилоксан или полиизобутилен |
RU2762896C2 (ru) | 2016-12-20 | 2021-12-23 | Лтс Ломанн Терапи-Систем Аг | Трансдермальная терапевтическая система, содержащая азенапин |
JP2020525545A (ja) | 2017-06-26 | 2020-08-27 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム |
KR20210022656A (ko) | 2018-06-20 | 2021-03-03 | 에르테에스 로만 테라피-시스테메 아게 | 아세나핀을 함유하는 경피 치료 시스템 |
CN110183457A (zh) * | 2019-06-27 | 2019-08-30 | 浙江天顺药业有限公司 | 一种阿塞那平及其制备方法 |
CN110606852B (zh) * | 2019-08-13 | 2021-02-05 | 浙江奥翔药业股份有限公司 | 制备阿塞那平的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
CN1861604B (zh) * | 2005-04-07 | 2011-08-31 | 欧加农股份有限公司 | 阿色纳品马来酸盐的晶型 |
-
2007
- 2007-06-27 TW TW096123323A patent/TW200817414A/zh unknown
- 2007-07-03 MX MX2008016490A patent/MX2008016490A/es active IP Right Grant
- 2007-07-03 DE DE602007002826T patent/DE602007002826D1/de active Active
- 2007-07-03 PT PT07801417T patent/PT2044076E/pt unknown
- 2007-07-03 ES ES07801417T patent/ES2333488T3/es active Active
- 2007-07-03 JP JP2009517030A patent/JP2010503611A/ja not_active Withdrawn
- 2007-07-03 PL PL07801417T patent/PL2044076T3/pl unknown
- 2007-07-03 AT AT07801417T patent/ATE445620T1/de active
- 2007-07-03 CA CA002655670A patent/CA2655670A1/fr not_active Abandoned
- 2007-07-03 WO PCT/EP2007/005876 patent/WO2008003460A1/fr active Application Filing
- 2007-07-03 EP EP07801417A patent/EP2044076B1/fr active Active
- 2007-07-03 DK DK07801417.2T patent/DK2044076T3/da active
- 2007-07-03 SI SI200730116T patent/SI2044076T1/sl unknown
- 2007-07-03 CN CN2007800254650A patent/CN101484456B/zh not_active Expired - Fee Related
- 2007-07-04 AR ARP070102980A patent/AR061811A1/es unknown
-
2008
- 2008-12-23 ZA ZA200810859A patent/ZA200810859B/xx unknown
-
2009
- 2009-07-14 HK HK09106284.3A patent/HK1127044A1/xx not_active IP Right Cessation
-
2010
- 2010-01-05 CY CY20101100007T patent/CY1109707T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
MX2008016490A (es) | 2009-01-22 |
DK2044076T3 (da) | 2010-02-01 |
EP2044076A1 (fr) | 2009-04-08 |
PT2044076E (pt) | 2010-01-20 |
SI2044076T1 (sl) | 2010-01-29 |
CN101484456B (zh) | 2011-09-07 |
PL2044076T3 (pl) | 2010-03-31 |
CN101484456A (zh) | 2009-07-15 |
CY1109707T1 (el) | 2014-04-09 |
WO2008003460A1 (fr) | 2008-01-10 |
JP2010503611A (ja) | 2010-02-04 |
EP2044076B1 (fr) | 2009-10-14 |
ATE445620T1 (de) | 2009-10-15 |
TW200817414A (en) | 2008-04-16 |
ES2333488T3 (es) | 2010-02-22 |
CA2655670A1 (fr) | 2008-01-10 |
DE602007002826D1 (de) | 2009-11-26 |
AR061811A1 (es) | 2008-09-24 |
HK1127044A1 (en) | 2009-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200810859B (en) | Process for the preparation of asenapine and intermediate products used in said process | |
EP2123260A4 (fr) | Composition de liposome et son procédé de préparation | |
IL198847A (en) | Process for making 2-imino-thiazolidine-4-on and several such histories | |
EP2035602A4 (fr) | Produit à revêtement électrolytique et procédé de préparation de celui-ci | |
EP2209625A4 (fr) | Objets et leurs procédés de fabrication | |
IL193236A0 (en) | Novel pyrone-indole derivatives and process for their preparation | |
IL215059A (en) | Liposome preparation that includes an arboline and a process for its preparation | |
HK1138517A1 (en) | Revaprazan-containing solid dispersion and process for the preparation thereof | |
EP2230935A4 (fr) | Produit alcoolique solide et procédé | |
PL2096937T3 (pl) | Sposób wytwarzania produktów herbacianych o zwiększonej zawartości teaflawiny | |
EP2349228B8 (fr) | Produit source de fer sous forme de capsules et son procédé de préparation | |
HK1135852A1 (en) | Anti-biocontaminant products and processes for making the same | |
IL200873A0 (en) | Novel benzamide derivatives and process for the preparation thereof | |
ZA200809772B (en) | Detergent product and process for its preparation and use thereof | |
EP1834624A4 (fr) | Préparation thérapeutique et procédé d'élaboration de ladite préparation | |
GB0613840D0 (en) | Methods and products for in vitro genotyping | |
EP2034846A4 (fr) | Produit laitier et procédé pour sa préparation | |
ZA200902899B (en) | Product and process | |
IL184592A0 (en) | Process for the preparation of boronic acids and derivatives thereof | |
ZA200904979B (en) | Herbal composition and process for its preparation | |
HU0500291D0 (en) | Fasteners, methods for making fasteners and use of fasteners in products | |
GB0613826D0 (en) | Process and product | |
IL194737A0 (en) | 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof | |
GB0607488D0 (en) | Composition and process | |
GB0605004D0 (en) | Composition and process |